The Incidence Rate of Non-Hodgkin’s Lymphoma in Saudi Arabia: An Observational Descriptive Population Based Epidemiological Study from the Saudi Cancer Registry (2006–2016)
DOI:
https://doi.org/10.3889/oamjms.2023.11566Keywords:
Non-Hodgkin’s lymphoma, Saudi cancer registry, Crude incidence rate, Age-standardized incidence rate, Epidemiological analysisAbstract
Introduction: Non-Hodgkin’s lymphoma (NHL) consists of several hematologic malignancies arising from B, T lymphocytes or natural killer lymphocytes, and nearly 85–90% originates from B lymphocytes. This current study illustrates frequency of diagnosed NHL cases, age-standardized incidence rate (ASIR) and crude incidence rate (CIR) by age group, year of diagnosis and administrative regions for identifying the distribution, pattern and real condition of NHL in Saudi Arabia.
Methodology: In this study, an epidemiological analysis of NHL cases is conducted on registered cases between 2006 and 2016 from Saudi cancer registry (SCR). For statistical analysis, t-test, sex ratio, Kruskal–Wallis and descriptive statistics were performed by SPSS version 20.0.
Results: A total of 8019 NHL cases were documented from reported from January 2006 to December 2016. Among males, Riyadh region had the highest overall ASIR at 7.9 followed by Eastern region at 6.9 per 100,000 males and lowest overall ASIRs were observed in Jazan and Hail region at 3.5, and the Northern region at 3.9 per 100,000 males. The highest overall ASIR among females was reported in the Riyadh region at 6.9 and Eastern region at 5.2 per 100,000 females and lowest overall ASIR was documented in the Jazan region at 2.2, followed by Hail at 2.4. The overall age-standardized incidence sex ratio of NHL was found to be 1.3 per100,000 in Saudi Arabia.
Conclusion: This study concluded an increase in crude incidence rates and age-standardized incidence rates NHL among Saudi population. Highest overall ASIRs for NHL among males and females from 2006 to 2016 were documented in Riyadh and Eastern region. While, lowest overall ASIRs among males and females were documented in the Jazan and Hail region.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Swerdlow S, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-90. https://doi.org/10.1182/blood-2016-01-643569 PMid26980727 DOI: https://doi.org/10.1182/blood-2016-01-643569
Chiu BC, Hou N. Epidemiology and etiology of non-hodgkin lymphoma. Cancer Treat Res. 2015;165:1-25. https://doi.org/10.1007/978-3-319-13150-4_1 PMid25655604 DOI: https://doi.org/10.1007/978-3-319-13150-4_1
Armitage JO, Gascoyne RD, Lunning MA, Cavalli F. Non-hodgkin lymphoma. Lancet. 2017;390(10091):298-310. https://doi.org/10.1016/S0140-6736(16)32407-2 PMid28153383 DOI: https://doi.org/10.1016/S0140-6736(16)32407-2
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492 PMid30207593 DOI: https://doi.org/10.3322/caac.21492
Alelyani RH, Alghamdi AH, Almughamisi TA, Alshareef AM, Kadasa AN, Alrajhi AM, et al. Incidence and risk factors of infections among diffuse large B-cell lymphoma and classical Hodgkin’s lymphoma patients in a tertiary care center in Saudi Arabia: A retrospective cohort study. Cureus. 2023;15(3):e35922. https://doi.org/10.7759/cureus.35922 PMid36911585 DOI: https://doi.org/10.7759/cureus.35922
Sun H, Xue L, Guo Y, Du J, Nan K, Li M. Global, regional and national burden of non-Hodgkin lymphoma from 1990 to 2017: Estimates from global burden of disease study in 2017. Ann Med. 2022;54(1):633-45. https://doi.org/10.1080/07853890.2022.2039957 PMid35196922 DOI: https://doi.org/10.1080/07853890.2022.2039957
Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF, et al. Etiologic heterogeneity among non- Hodgkin lymphoma subtypes: The InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014;2014(48):130-44. https://doi.org/10.1093/jncimonographs/ lgu013 PMid25174034
Lu YS, Chiang PM, Huang YC, Yang SJ, Hung LY, Medeiros LJ, et al. Overexpression of interleukin-20 correlates with favourable prognosis in diffuse large B-cell lymphoma. Pathology. 2023;55(1):94-103. https://doi.org/10.1016/j.pathol.2022.07.007 PMid36175183 DOI: https://doi.org/10.1016/j.pathol.2022.07.007
Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: A synthetic analysis. Lancet Glob Health. 2016;4(9):e609-16. https://doi.org/10.1016/S2214-109X(16)30143-7 PMid27470177 DOI: https://doi.org/10.1016/S2214-109X(16)30143-7
Shiels MS, Engels EA. Evolving epidemiology of HIV-associated malignancies. Curr Opin HIV AIDS. 2017;12(1):6-11. https://doi.org/10.1097/COH.0000000000000327 PMid27749369 DOI: https://doi.org/10.1097/COH.0000000000000327
Chekol D, Bedimo M, Mulugeta Y, Bantie GM. Determinants of non-Hodgkin’s lymphoma at Felegehiwot specialized hospital, North West Ethiopia: A case-control study. PLoS One. 2020;15(12):e0243561. https://doi.org/10.1371/journal.pone.0243561 PMid33370329 DOI: https://doi.org/10.1371/journal.pone.0243561
Anari SR, Kheirkhah B, Amini K, Roozafzai F. Expression of microRNA-155 in patients with non-Hodgkin lymphoma, Coronavirus disease 2019, or both: A cross-sectional study. Iran J Med Sci. 2023;48(1):26-34. https://doi.org/10.30476/IJMS.2022.91669.2282 PMid36688191
Aggarwal R, Ranganathan P. Study designs: Part 2-descriptive studies. Perspect Clin Res. 2019;10(1):34-6. https://doi.org/10.4103/picr.picr_154_18 PMid30834206 DOI: https://doi.org/10.4103/picr.PICR_154_18
Almatroudi A. The incidence rate of colorectal cancer in Saudi Arabia: An observational descriptive epidemiological analysis. Int J Gen Med. 2020;13:977-90. https://doi.org/10.2147/IJGM.S277272 PMid33149661 DOI: https://doi.org/10.2147/IJGM.S277272
Beishuizen A, Mellgren K, Andrés M, Auperin A, Bacon CM, Bomken S, et al. Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma. Lancet Haematol. 2023;10(3):e213-24. https://doi.org/10.1016/s2352-3026(22)00374-x PMid36858678 DOI: https://doi.org/10.1016/S2352-3026(22)00374-X
Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al. AJCC Cancer Staging Manual. Vol. 1024. Berlin, Germany: Springer: 2017. DOI: https://doi.org/10.1007/978-3-319-40618-3
Al-Ahmadi K, Al-Zahrani A. NO(2) and cancer incidence in Saudi Arabia. Int J Environ Res Public Health. 2013;10(11):5844-62. https://doi.org/10.3390/ijerph10115844 PMid24192792 DOI: https://doi.org/10.3390/ijerph10115844
Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of Vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014;14(5):342-57. https://doi.org/10.1038/nrc3691 PMid24705652 DOI: https://doi.org/10.1038/nrc3691
Hussain AN, Alkhenizan AH, El Shaker M, Raef H, Gabr A. Increasing trends and significance of hypovitaminosis D: A population-based study in the Kingdom of Saudi Arabia. Arch Osteoporos. 2014;9:190. https://doi.org/10.1007/s11657-014-0190-3 PMid25213798 DOI: https://doi.org/10.1007/s11657-014-0190-3
Al-Elq AH. The status of Vitamin D in medical students in the preclerkship years of a Saudi medical school. J Family Community Med. 2012;19(2):100-4. https://doi.org/10.4103/2230-8229.98293 PMid22870413 DOI: https://doi.org/10.4103/2230-8229.98293
Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, et al. Prospective study of predictors of Vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006;98(7):451-9. https://doi.org/10.1093/jnci/djj101 PMid16595781 DOI: https://doi.org/10.1093/jnci/djj101
Lim U, Freedman DM, Hollis BW, Horst RL, Purdue MP, Chatterjee N, et al. A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer. 2009;124(4):979-86. https://doi.org/10.1002/ijc.23984 PMid19035445 DOI: https://doi.org/10.1002/ijc.23984
Al-Hanawi MK, Keetile M. Socio-economic and demographic correlates of non-communicable disease risk factors among adults in Saudi Arabia. Front Med (Lausanne). 2021;8:605912. https://doi.org/10.3389/fmed.2021.605912 PMid33889582 DOI: https://doi.org/10.3389/fmed.2021.605912
Mitri J, Castillo J, Pittas AG. Diabetes and risk of Non-Hodgkin’s lymphoma: A meta-analysis of observational studies. Diabetes Care. 2008;31(12):2391-7. https://doi.org/10.2337/dc08-1034 PMid19033419 DOI: https://doi.org/10.2337/dc08-1034
Wang Y, Liu X, Yan P, Bi Y, Liu Y, Zhang ZJ. Association between Type 1 and Type 2 diabetes and risk of non-Hodgkin’s lymphoma: A meta-analysis of cohort studies. Diabetes Metab. 2020;46(1):8-19. https://doi.org/10.1016/j.diabet.2019.04.006 PMid31039401 DOI: https://doi.org/10.1016/j.diabet.2019.04.006
Al-Hanawi MK, Chirwa GC, Pemba LA, Qattan AM. Does prolonged television viewing affect Body Mass Index? A case of the Kingdom of Saudi Arabia. PLoS One. 2020;15(1):e0228321. https://doi.org/10.1371/journal.pone.0228321 PMid31999775 DOI: https://doi.org/10.1371/journal.pone.0228321
Alghamdi IG, Hussain II, Alghamdi MS, Dohal AA, Alghamdi MM, El-Sheemy MA. Incidence rate of non-Hodgkin’s lymphomas among males in Saudi Arabia: An observational descriptive epidemiological analysis of data from the Saudi Cancer Registry, 2001-2008. Int J Gen Med. 2014;7:311-7. https://doi.org/10.2147/ijgm.s63645 PMid25028562 DOI: https://doi.org/10.2147/IJGM.S63645
Alghamdi IG, Hussain II, Alghamdi MS, El-Sheemy MA. The incidence rate of corpus uteri cancer among females in Saudi Arabia: An observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001-2008. Int J Womens Health. 2014;6:141-7. https://doi.org/10.2147/IJWH.S56687 PMid24511244 DOI: https://doi.org/10.2147/IJWH.S56687
Altowairqi MY, Alyousef MY, Ghandour MK, Alrashed AA, Aljebrin YJ, Alotheem GA, et al. Survival and epidemiologic trends of lymphomas in Saudi Arabia: A 10-year report from a tertiary care hospital. Saudi J Med Med Sci. 2022;10(1):31-5. https://doi.org/10.4103/sjmms.sjmms_200_21 PMid35283704 DOI: https://doi.org/10.4103/sjmms.sjmms_200_21
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Malak Yahia Qattan (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
